Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2007-04-16A Randomised Double-Blind Trial of Low and High Frequency Stimulation rTMS (Repetitive Transcranial Magnetic Stimulation) In Major Depression
-
CLINICAL_TRIALS study record update · 2007-03-27A 12-Month Open-Label Evaluation of the Long-Term Safety of DVS-233 SR in Outpatients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2007-03-02Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2007-02-09Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors - a Feasibility Study
-
CLINICAL_TRIALS study record update · 2007-01-26Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2006-09-08A Randomized Trial of the Cost Effectiveness of Generalist Care Managers for the Treatment of Depression in Medicaid Recipients
-
CLINICAL_TRIALS study record update · 2006-07-25Switching to Duloxetine From Other Antidepressants: A Regional Multicentre Trial Comparing Two Switching Techniques
-
CLINICAL_TRIALS study record update · 2006-07-24The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features
-
CLINICAL_TRIALS study record update · 2006-07-19Protocol F1J-US-HMBY Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression
-
CLINICAL_TRIALS study record update · 2006-07-19Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
-
CLINICAL_TRIALS study record update · 2006-06-09A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression.